Τα καλύτερα I3 podcast (2024)

1
Diagnosis and Management of Dedifferentiated Liposarcoma: A Multidisciplinary Task Force Podcast 28:57

8d ago28:57

28:57

Gain valuable insights into the complexities of diagnosing and managing dedifferentiated liposarcoma (DDLPS) and earn free CME credit with our latest podcast. This episode features expert guidance from Dr. Richard F. Riedel of Duke University and Dr. Candace L. Haddox of Dana-Farber Cancer Institute. Delve into the latest on identifying MDM2 and CD…

1
National Alzheimer Disease Awareness Month: Advances in Diagnosis and Research With Nathaniel Chin, MD 14:25

28d ago14:25

14:25

Click the links below for the full activity! Online Accredited CME/NCPD Activity: https://i3health.com/course-information/Alzheimer-disease Live In-Person or Virtual Meeting: https://i3health.com/live/Exploring%20Advances%20in%20the%20Early%20Diagnosis%20and%20Treatment%20of%20Alzheimer%20DiseaseNovember is National Alzheimer Disease Awareness Mont…

1
105: T. Rowe Price's Jessica Sclafani 29:20

1M ago29:20

29:20

In episode 105 of the [i3] Institutional Investment Podcast, we speak with Jessica Sclafani, a Global Retirement Strategist with US fund manager T. Rowe Price, which manages $1.6 trillion in total assets on behalf of clients. Retirement is a more complex phase than wealth accumulation and it needs a more sophisticated approach to deliver good outco…

1
Exclusive Sneak Peek: Unlocking What's Next in Genetic Counseling and Cancer Care! 9:30

1M ago9:30

9:30

i3 Health is pleased to invite you to Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, a free, live webinar held on November 7 at 10:00 am Eastern and November 19 at 11:30 am Eastern. This interview features an exclusive preview from the two webinar co-chairs, Dr. Filipa Lynce, Director of the Inflammatory Breast …

1
104: State Super's John Livanas 45:19

2M ago45:19

45:19

John Livanas is the Chief Executive Officer of State Super, the $37 billion superannuation fund for public service and public sector workers in NSW. In this episode, we talk about the use of defensive overlays, dealing with the COVID drawdown and machine learning in investments. Enjoy the show!Overview of podcast with John Livanas, Chief Executive …

1
Additional Advances in Head and Neck Squamous Cell Carcinoma With Deborah Wong, MD, PhD 9:12

2M ago9:12

9:12

Dr. Deborah Wong, Director of the Medical Oncology Program and Clinical Trials Program for Head and Neck Squamous Cell Cancers (HNSCC) and an Associate Clinical Professor of Medicine at the University of California Los Angeles (UCLA) is currently serving as co-chair of i3 Health’s accredited CME/NCPD activity, Recurrent and Metastatic HNSCC, Harnes…

1
Navigating Patients Through the CKD Journey by Enhancing Value-Based Care - CPE & Interview 1:55:41

2M ago1:55:41

1:55:41

Jeff Sperry, PharmD, BCPS, a Clinical Pharmacist at UCHealth Memorial Hospital, sat down with the Pharmacy Podcast Network to discuss additional advances in chronic kidney disease since recording the i3Health CPE-accredited activity, Slowing Progression of Chronic Kidney Disease Through Value-Based Care. Following the interview, continue listening …

1
Additional Advances in Alzheimer Disease Research and Clinical Trials With Nathaniel Chin, MD 14:18

2M ago14:18

14:18

Dr. Nathaniel Chin, Associate Professor of Medicine in the Division of Geriatrics and Gerontology at the University of Wisconsin-Madison, is currently serving as chair of i3 Health’s accredited CME/NCPD activity, Exploring Advances in the Early Diagnosis and Treatment of Alzheimer Disease. With new developments in the field occurring over recent mo…

1
Mitigating Disease Burden and Health Care Disparities in Relapsed/Refractory MM 33:18

3M ago33:18

33:18

Listen now to this CME-accredited podcast, part of the Multiple Myeloma Task Force series, where we will explore strategies for mitigating disease burden and addressing health care disparities in patients with relapsed/refractory multiple myeloma. This session brings together expert insights from Task Force Co-Chairs, Dr. Sikander Ailawadhi, Profes…

1
Multicancer Early Detection Technologies: Module 3 - Implementing MCED Testing in Clinical Practice 23:43

3M ago23:43

23:43

Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application.In Module 3 of our CME podcast, Dr. Charles Vega, Clinical Professor at the University of California, Irvine, will review the latest clinical trial data on MCED tests for gynecologi…

1
103: Janus Henderson's Matt Culley 44:19

3M ago44:19

44:19

Matthew Culley is a Portfolio Manager on the Emerging Market Equity Team at Janus Henderson Investors. In this podcast, we talk about the best performing markets, tensions around China, the impact of the US elections and fighter jets. Enjoy the Show!Overview of [i3] Podcast with Matt Culley, Janus Henderson Investors02:00 I initially wanted to beco…

1
Multicancer Early Detection Technologies: Module 1 - Science Behind Cancer Screening 20:16

3M ago20:16

20:16

Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. Listen now to Module 1 and join Dr. Charles Vega, a distinguished Clinical Professor from UC Irvine, as he explores the cutting-edge realm of multicancer early detection (MCED). Dr…

1
Multicancer Early Detection Technologies: Module 2 - Clinical Evidence for MCED Testing 20:13

3M ago20:13

20:13

Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application.Join Dr. Charles Vega in Module 2 of our CME podcast as he delves into the cutting-edge world of multicancer early detection (MCED) tests. With nearly 2 million new cancer cases exp…

1
102: Qantas Super's Andrew Spence 44:49

4M ago44:49

44:49

In episode 102 of the [i3] Podcast, we speak with Andrew Spence, Chief Investment Officer of the $9 billion corporate super fund Qantas Super. Qantas Super recently announced to merge with ART and we took the opportunity to look back at the investment strategy that Spence put in place as the fund's first CIO, the innovations along the way and lesso…

1
Additional Advances in Rett Syndrome Research and Clinical Trials With Timothy John Feyma, MD 5:00

4M ago5:00

5:00

Dr. Timothy John Feyma, Pediatric Neurologist at Gillette Children’s Hospital, is currently serving as chair of i3 Health’s CME/NCPD activity, Exploring Novel Treatments for Rett Syndrome. With new developments in the field occurring over recent months, Dr. Feyma sat down with us again to share new updates in treatment and management of Rett syndro…

1
101: ECP's Damon Callaghan and Sam Byrnes 47:22

5M ago47:22

47:22

In episode 101 of the [i3] Podcast, we speak with Damon Callaghan and Sam Byrnes of asset management firm ECP. ECP was established by Dr. Manny Pohl of Hyperion Asset Management fame and in this episode we talk about the opportunities and challenges of artificial intelligence when investing in Australian equities. Enjoy the show!01:00 How we got st…

1
Practice-Changing Advances in the Management of Hemophilia 42:37

5M ago42:37

42:37

In this podcast, hear expert perspectives on practice-changing advances in the treatment and personalized management of patients with hemophilia from Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology/Oncology, and Professor of Pediatrics at Keck School of Medicine of USC; and Dr. Jennifer Davila, Co…

1
Early-Stage Non–Small Cell Lung Cancer: Answers to Frequently Asked Questions 5:58

6M ago5:58

5:58

In this video, Dr. Jamie E. Chaft, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Leveraging the Growing Arsenal of Therapies for Early-Stage Non–Small Cell Lung Cancer (NSCLC), chaired by Dr. Helena Yu. Dr. Chaft shares insights …

1
Cold Agglutinin Disease: Answers to Frequently Asked Questions With Catherine Broome, MD 4:53

6M ago4:53

4:53

In this video, Dr. Catherine M. Broome, Professor of Medicine at Georgetown University Medical Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Putting the Freeze on Cold Agglutinin Disease (CAD). Dr. Broome shares insights into resources she recommends for patients with CAD, the role of thrombop…

1
100: Private Equity Co-investments with Neuberger Berman 41:58

6M ago41:58

41:58

It is our 100th episode of the [i3] Podcast and we are celebrating this with an in-depth discussion on innovation in private equity, especially mid-life transactions, with David Morse, Managing Director and Global Co-Head of Private Equity Co-Investments at Neuberger Berman. Enjoy the show! Overview of Podcast with David Morse of Neuberger Berman01…

1
Getting Ahead of the ALS Curve: Module 2 – Disease-Modifying Therapies for ALS: Weighing the Options 16:51

6M ago16:51

16:51

In Module 2 of this microlearning series and podcast, Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts Hospital and Healey & AMG Center for ALS, and Associate Professor of Physical Medicine and Rehabilitation (PM&R) at Spaulding Rehabilitation Hospital of Harvard Medical School, will share strategie…

1
Getting Ahead of the ALS Curve: Module 1 – Enabling Earlier Detection of ALS 24:10

6M ago24:10

24:10

In Module 1 of this microlearning series and podcast, Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts Hospital and Healey & AMG Center for ALS, and Associate Professor of Physical Medicine and Rehabilitation (PM&R) at Spaulding Rehabilitation Hospital of Harvard Medical School, will share strategie…

1
Additional Advances in Triple-Negative Breast Cancer Research and Trials: Sara M. Tolaney, MD, MPH 7:22

6M ago7:22

7:22

Last year, Dr. Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, served as co-chair of i3 Health’s webinar and online activity, Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer (TNBC). With numerous advances in TNBC research occurring since then, Dr. Tolaney sat down…

1
Additional Advances in Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP 5:54

7M ago5:54

5:54

Dr. Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, Fred Hutchinson Cancer Center, is currently serving as chair of i3 Health’s online activity and fellows meeting series, Leveraging BCMA-Directed Therapies for Improved Patient Outcomes in Relapsed/Refractory Multiple Myeloma. Since recording…

1
Acid Sphingomyelinase Deficiency: Answers To Frequently Asked Questions With Neal Weinreb, MD 11:15

7M ago11:15

11:15

In this video, Dr. Neal Weinreb, Voluntary Associate Professor for Human Genetics at the University of Miami Miller School of Medicine, answers questions asked by the audience during his CME/NCPD–approved activity with i3 Health, Exploring Treatment Advances for Acid Sphingomyelinase Deficiency (ASMD) in Adults. Dr. Weinreb shares insights into scr…

1
Recurrent/Metastatic HNSCC: Answers To Frequently Asked Questions With Assuntina G. Sacco, MD 11:15

7M ago11:15

11:15

In this video, Dr. Assuntina G. Sacco, Associate Professor of Internal Medicine, Co-Director of the Hanna and Mark Gleiberman Head and Neck Cancer Center, and Disease Team Leader–Head and Neck at UC San Diego Moores Cancer Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Recurrent/Metastatic Head…

1
99: Global Equities with Janus Henderson 39:35

7M ago39:35

39:35

In episode 99 of the [i3] Podcast, we speak with Julian McManus, who is a Portfolio Manager on the Global Alpha Equity Team at Janus Henderson Investors. We spoke about global equities, the role of the Magnificent 7, Japanese equities and hybrid cars. Enjoy the show!Overview of Podcast with Julian McManus, Janus Henderson Investors02:00 Getting int…

1
Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD 10:39

7M ago10:39

10:39

Last year, Brian Rubin, MD, PhD, Chair of Pathology and Laboratory Medicine and the Chief of Diagnostics at the Cleveland Clinic, served as co-chair for i3 Health's continuing medical education CME NCPD #virtualtumorboard: Multidisciplinary Management of Advanced Soft Tissue Sarcoma. In this interview, Dr. Rubin sat down with Oncology Data Advisor …

1
98: Artificial Intelligence in Wealth Management 1:01:40

8M ago1:01:40

1:01:40

In episode 98 of the [i3] Podcast, we are speaking with Will Liang, who is an executive director at MA Financial Group, but is also well-known for his time with Macquarie Group, where he worked for more than a decade, including as Head of Technology for Macquarie Capital Australia and New Zealand. We discuss the application of AI in financial servi…

1
Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research: Christopher Lieu, MD 8:11

8M ago8:11

8:11

Dr. Christopher Lieu, Associate Director of Clinical Research at the University of Colorado Cancer Center and Vice Chair of the National Comprehensive Cancer Network (NCCN), is currently serving as chair of i3 Health's online activity, live webinar, and meeting series, Hitting the Target in HER2-Positive Metastatic Colorectal Cancer. With numerous …

1
Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD 8:47

8M ago8:47

8:47

Dr. Spero Cataland, Professor of Internal Medicine and the Benign Hematology Section Head at The Ohio State University, Wexner Medical Center, is currently serving as chair of i3 Health's free CME/NCPD activity and Hematology Fellows Lecture Series, Current Standards and New Directions in Treatment of Acquired Thrombotic Thrombocytopenic Purpura (a…

1
Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD 7:18

8M ago7:18

7:18

Last year, Jaffer Ajani, MD, Professor in the Department of Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center, served as co-chair of i3 Health's Virtual Tumor Board, Building Comprehensive Care Plans in Esophagogastric Cancers, along with Lei Zhao, MD, PhD, Assistant Professor of Pathology at Brigham and Women's Hospital, and Kell…

1
97: Talking Leadership with Felicity Walsh 48:36

8M ago48:36

48:36

In this episode of the [i3] Podcast, we speak with Felicity Walsh, Managing Director and Head of Australia & New Zealand for Franklin Templeton about leadership, fostering a great work culture, mentorship and lab coats. Enjoy the show! Overview of Podcast with Felicity Walsh, Franklin Templeton01:00 Hanging up the chemistry lab coat and safety spec…

1
96: T Rowe Price's Maria Elena Drew – Towards Net Zero Portfolios 41:50

9M ago41:50

41:50

In episode 96 of the [i3] Podcast, we speak with Maria Elena Drew, Director of Research – Responsible Investing, at T. Rowe Price about the challenges and opportunities of transforming investments into net zero portfolios. How does it affect your objectives and engagement with companies? Enjoy the show!Overview of Podcast with Maria Elena Drew, T. …

1
95: CAIA's John Bowman – Alternatives, ESG and TPA 51:31

9M ago51:31

51:31

John Bowman is President of the Chartered Alternative Investment Analyst (CAIA) Association. In this episode we look back at the growth of the alternative investment industry, in particular private equity, discuss ESG and take a look at the upcoming paper on the total portfolio approachOverview of podcast with John Bowman, CAIA02:00 I got involved …

1
Highlights of Multiple Myeloma Research Presented at ASH With Urvi Shah, MD 16:13

10M ago16:13

16:13

At the recent American Society of Hematology (ASH) Annual Meeting, numerous updates were presented with the potential to impact practice in relapsed/refractory multiple myeloma. While at the meeting, Urvi Shah, MD, Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center, shares some of most significant highlights of the…

1
94: ART's Andrew Fisher on Scale 37:18

10M ago37:18

37:18

Andrew Fisher is the Head of Investment Strategy at the Australian Retirement Trust (ART), a $260 billion pension fund in Australia. In this episode of the [i3] Podcast, we reflected on the merger with QSuper and the implications the larger scale of the fund has on the investment strategy. Enjoy the show!Overview of Podcast with Andrew Fisher, 2024…

1
93: NextEnergy Capital's Mike Bonte-Friedheim 38:24

11M ago38:24

38:24

In episode 93 of the [i3] Podcast, we speak with Michael Bonte-Friedheim, the Founding Partner and Group CEO of NextEnergy Capital, a firm that specialises in investing in solar energy plants. We talk about the role of subsidies, the growth of the sector and the fact that ESG in solar isn't just about renewable energyOverview of Podcast with Michae…

1
92: Benefit Street Partners' Mike Comparato 33:04

12M ago33:04

33:04

Mike Comparato is Managing Director and Head of Real Estate at Benefit Street Partners, a credit-focused alternative asset management firm owned by Franklin Templeton. In this episode, we cover Mike's views on the turmoil that the commercial real estate market is facing and the impending debt maturity wall that could set off a hurricane.Overview of…

1
Additional Advances in Advanced Prostate Cancer With Tanya Dorff, MD 8:45

12M ago8:45

8:45

Recently, Tanya Dorff, MD, Division Chief of the Genitourinary Disease Program at City of Hope, served as faculty for i3 Health's CME/NCPD-approved activity, Evolving Treatment Concepts and New Data in Advanced Prostate Cancer. Since recording, a plethora of new data and treatment options have been made available for prostate cancer, as well as add…

1
91: Celebrating 20 Years of NZ Super 48:03

1y ago48:03

48:03

This year we celebrate 20 years of New Zealand Super. We speak to the fund's CEO, Matt Whineray, about the evolution of the fund throughout the years, do a deep dive into its strategic tilting program and cover responsible investing, AI and much more. Enjoy the show!Overview of Podcast with Matt Whineray, CEO of NZ Super on 20 years of the fund01:0…

1
Additional Advances in SCLC Radiotherapy With Henry Park, MD, MPH + Free CME/NCPD/CPE Podcast 52:30

1y ago52:30

52:30

Recently, Dr. Henry Park, Chief of Thoracic Radiotherapy at Smilow Cancer Network of Yale School of Medicine, served as faculty for i3 Health’s CME/NCPD/CPE–approved activity, Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer (SCLC). This month, numerous updates in the use of radiotherapy for SCLC were presented…

1
90: Janus Henderson 2023 Australian Insurance Report 36:53

1y ago36:53

36:53

In this episode of the [i3] Podcast, we speak with Jay Sivapalan, Head of Australian Fixed Income at Janus Henderson about the company's 2023 Australian Insurance Report, a survey of insurance companies and their plans for their investment portfolios. The survey found that no less than 9 out of every 10 insurers plan to change their strategic asset…

1
89: Michael Kollo on Artificial Intelligence 41:13

1y ago41:13

41:13

In episode 88 of the [i3] Podcast we speak with Dr. Michael Kollo about artificial intelligence and large language models such as chatGPT. We talk about their application to the institutional investment industry and discuss why Australia is so distrustful of AI. Please enjoy the show!Overview of Podcast with Dr. Michael Kollo 01:00 Getting involved…

1
Daramao - 3D à serviço da saúde 1:01:15

1y ago1:01:15

1:01:15

Pois é, pois é, entrevista dessa semana... sou eu! A Lauriane BEL da Associação Dar a mão me entrevistou, como parte do programa de lives deles para trazer informações e divulgar as ações da associação à respeito da Agenesia de membro, destacando a questão da petição online! Confira tudo nos links abaixo: Associação dar à mão http://instagram.com/d…

1
88: HMC Capital's David Di Pilla 30:47

1y ago30:47

30:47

David Di Pilla is Managing Director and Group Chief Executive Officer of HMC Capital, a diversified alternative investment firm. In this episode, we speak about the challenges of building a new investment firm during the COVID-19, the attraction of healthcare real estate and the taking a private equity approach to listed markets. Please enjoy the s…

1
87: Janus Hendersons' Thomas Haugaard – Emerging Market Debt 44:28

1y ago44:28

44:28

In this episode, we speak with Thomas Haugaard, Portfolio Manager for Emerging Market Debt at Janus Henderson Investors. Haugaard, a former economist, talks passionately about why emerging markets form such an interesting investment universe, the influence of geopolitics on debt securities and the risks from climate change. Please enjoy the show!Ov…

1
Bate papo com Eros 2:01:31

1+ y ago2:01:31

2:01:31

Hoje fizemos um super bate papo com o grande designer e empreendedor Eros da @estudioetech, (@erosjunior_sjc), onde ele conta sua trajetória, suas contribuições para as ações como AME o Thomas, e sua trajetória pelo maravilhoso mundo do 3D e muitos outros recônditos! Gostou do papo? Manda um alô para contato@impresso3d.com.br…

1
86: Deloitte's Craig Roodt – APRA, performance test and good governance 51:54

1+ y ago51:54

51:54

Craig Roodt is Director of Investment Governance and Risk at Deloitte Touche Tohmatsu and is also known for his time with the Australian Prudential Regulation Authority (APRA). In this episode, we speak about the governance challenges of in-sourcing asset management functions by pension funds, the Your Future, Your Super performance test and some t…

1
85: PGIM's Jakob Wilhelmus on Food Security 30:01

1+ y ago30:01

30:01

In episode 85 of the [i3] Podcast, we speak with Jakob Wilhelmus, who is Director of Thematic Research at PGIM about their new report into food security and the changing food system. We spoke about the impact on the global economy and investment opportunities for institutional investors. Please enjoy the show!Overview of Podcast with Jakob Wilhelmu…

Podcasts που αξίζει να ακούσετε

I3 Podcasts

Podcasts που αξίζει να ακούσετε

Οδηγός γρήγορης αναφοράς